Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian
Western intelligence agencies eye neo-fascist fight clubs : ‘an international white supremacist movement’
19/10/2025
The Louvre heist, a burning airport and seven new saints : photos of the weekend
19/10/2025
How the west can stop the global south being strangled by debt | Heather Stewart
19/10/2025
‘Empty shelves, higher prices’ : Americans tell of cost of Trump’s tariffs
19/10/2025
A waiting list of thousands, and just five new homes for social rent : this city shows the depth of Britain’s housing crisis | John Harris
19/10/2025
Aston Villa stadium must not be a no-go area for Jews, says Ed Miliband
19/10/2025